TY - JOUR
T1 - Dystrophic neurite formation associated with age-related β amyloid deposition in the neocortex
T2 - Clues to the genesis of neurofibrillary pathology
AU - Vickers, James C.
AU - Chin, Devika
AU - Edwards, Ann Marie
AU - Sampson, Viola
AU - Harper, Clive
AU - Morrison, John
N1 - Funding Information:
We thank Dr. J. Kril (Department of Pathology, University of Sydney), Dr. J. Hilton (NSW Institute of Forensic Medicine), Dr. P. Blumbergs (Institute of Medical and Veterinary Science, Adelaide), and Dr. W. Blessing, Dr. W.-P. Gai, and Ms. R. Flook (Departments of Medicine and Human Physiology, Flinders University of South Australia) for the provision of non-AD cases utilized in this study. Cases bearing the ‘‘A’’ prefix were collected under the auspices of the Brain Bank Consortia (Adelaide) of the Australian National Health and Medical Research Council (NH&MRC) Network for Brain Research into Mental Disorders. AD cases were made available through the Institute of Biogerontology Research Tissue Donation Program (Sun City, Arizona, U.S.A.). This work was funded by grants/awards from the Tasmanian Masonic Centenary Medical Research Foundation, AMRAD Corp., the Royal College of Pathologists of Australasia, the Ian Potter Foundation, the MSD Foundation, the Department of Veterans Affairs, and the Acute Care Program (Royal Hobart Hospital) to J. Vickers as well as American National Institute for Health Grants AG06447 and AG05138 to J. H. Morrison. J. C. Vickers is a recipient of a R. D. Wright Research Fellowship from the NH&MRC.
PY - 1996/9
Y1 - 1996/9
N2 - The formation of dystrophic neurites associated with β amyloid plaques in Alzheimer's disease (AD) appears to involve a transformation of normal neuronal cytoskeletal proteins. In order to investigate what may be the earliest neuronal changes associated with the development of dystrophic neurites, we have examined the neurochemical profile of abnormal neuritic processes associated with the β amyloid deposition in non-AD, aged cases. In all non-AD individuals demonstrating some degree of β amyloid deposition in the superior frontal gyrus, clustered swollen and ring-like structures, located principally in layers II and III, were labeled with antibodies to phosphorylated and nonphosphorylated domains of the middle and high molecular weight neurofilament subunits. These abnormal neurites were not immunolabeled for tau or ubiquitin or stained with thioflavine S. Double labeling for neurofilaments and thioflavine S confirmed that these clusters of dystrophic neurites were associated with plaque-like deposits. These results show that anatomically and neurochemically specific forms of dystrophic neurites can occur in non-AD cases that contain β amyloid deposition. If these abnormal neurites correspond to an immature form of the dystrophic neurites found in the neuritic plaques of Alzheimer's disease, then neurofibrillary pathology associated with this disease may begin with an initial misprocessing and accumulation of neurofilament proteins. Furthermore, these data are consistent with the proposal that the development of neurofibrillary pathology may begin with neurofilamentous hypertrophy in damaged distal processes followed by reactive changes in the cell bodies of origin of these fibers involving cytoskeletal alterations that ultimately lead to neurofibrillary tangle formation.
AB - The formation of dystrophic neurites associated with β amyloid plaques in Alzheimer's disease (AD) appears to involve a transformation of normal neuronal cytoskeletal proteins. In order to investigate what may be the earliest neuronal changes associated with the development of dystrophic neurites, we have examined the neurochemical profile of abnormal neuritic processes associated with the β amyloid deposition in non-AD, aged cases. In all non-AD individuals demonstrating some degree of β amyloid deposition in the superior frontal gyrus, clustered swollen and ring-like structures, located principally in layers II and III, were labeled with antibodies to phosphorylated and nonphosphorylated domains of the middle and high molecular weight neurofilament subunits. These abnormal neurites were not immunolabeled for tau or ubiquitin or stained with thioflavine S. Double labeling for neurofilaments and thioflavine S confirmed that these clusters of dystrophic neurites were associated with plaque-like deposits. These results show that anatomically and neurochemically specific forms of dystrophic neurites can occur in non-AD cases that contain β amyloid deposition. If these abnormal neurites correspond to an immature form of the dystrophic neurites found in the neuritic plaques of Alzheimer's disease, then neurofibrillary pathology associated with this disease may begin with an initial misprocessing and accumulation of neurofilament proteins. Furthermore, these data are consistent with the proposal that the development of neurofibrillary pathology may begin with neurofilamentous hypertrophy in damaged distal processes followed by reactive changes in the cell bodies of origin of these fibers involving cytoskeletal alterations that ultimately lead to neurofibrillary tangle formation.
UR - http://www.scopus.com/inward/record.url?scp=0030249343&partnerID=8YFLogxK
U2 - 10.1006/exnr.1996.0133
DO - 10.1006/exnr.1996.0133
M3 - Article
C2 - 8797662
AN - SCOPUS:0030249343
SN - 0014-4886
VL - 141
SP - 1
EP - 11
JO - Experimental Neurology
JF - Experimental Neurology
IS - 1
ER -